HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy
Clinical trial NCT02061423 · COMPLETED
Trial details
- NCT number
- NCT02061423
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-08
- Primary completion
- 2019-02-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.